PARNAX LAB
Back to Balance Sheet
|
PARNAX LAB Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹74 Cr | ₹83 Cr | ₹63 Cr | ₹81 Cr | ₹54 Cr |
What is the latest Total Current Liabilities ratio of PARNAX LAB ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹74 Cr |
| Mar2024 | ₹83 Cr |
| Mar2023 | ₹63 Cr |
| Mar2022 | ₹81 Cr |
| Mar2021 | ₹54 Cr |
How is Total Current Liabilities of PARNAX LAB Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹74 Cr | -10.79 | |
| Mar2024 | ₹83 Cr | 32.18 | |
| Mar2023 | ₹63 Cr | -22.15 | |
| Mar2022 | ₹81 Cr | 48.93 | |
| Mar2021 | ₹54 Cr | - | |
Compare Total Current Liabilities of peers of PARNAX LAB
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PARNAX LAB | ₹157.8 Cr | -5% | 5.1% | 19.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹474,396.0 Cr | 1.8% | 5.6% | 16.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,990.0 Cr | 0.5% | 13.1% | 10.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,354.0 Cr | -2.7% | 5.1% | 42.4% | Stock Analytics | |
| CIPLA | ₹116,705.0 Cr | 2.1% | -0.6% | -4.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹94,790.0 Cr | -4% | -17.5% | -8.6% | Stock Analytics | |
PARNAX LAB Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PARNAX LAB | -5% |
5.1% |
19.9% |
| SENSEX | -0.9% |
-0.4% |
-6.1% |
You may also like the below Video Courses